News
Media
Medical World NewsPodcastsVideosInsightsPeer ExchangeMedia DayNews NetworkRoundtables
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Case StudiesWriters and Mentors

Subscribe

  • News
  • Media
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Antimicrobial Stewardship|
Bench to Bedside With SIDP|
C. difficile |
Clinical Corner|
Fungal Infections|
Hepatitis|
RSV: A New Era in Prevention
Advertisement

ELIZABETH HIRSCH, PHARMD, RPH

Advertisement

Articles by ELIZABETH HIRSCH, PHARMD, RPH

What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing?

ByELIZABETH HIRSCH, PHARMD, RPH
August 13th 2018

In addition to other updates, new breakpoints have been added for cefiderocol and meropenem-vaborbactam.

Advertisement

Latest Updated Articles

  • What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing?
    What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing?

    Published: August 13th 2018 | Updated:



Advertisement
Advertisement

Trending on Contagion Live

1

Understanding the Importance of Bird Migration as it Relates to Avian Influenza

2

Rapid HCV Test Provides Opportunity for Single Visit Diagnosis and Treatment Encounters

3

Qpex Biopharma’s New President Wants More Push-Pull Incentives, Opportunities for Young US Scientists

4

No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy

5

A Versatile Option for Complex Infections

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us